跳至主要内容
临床试验/IRCT20111206008307N34
IRCT20111206008307N34已完成2 期

Evaluation of the effect of metformin on cardiac troponin-I in STEMI patients treated with thrombolytic therapy

Tabriz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Ischemic heart diseases
  • undergoing of thrombolytic therapy
  • filling of consent form

排除标准

  • Elevation of troponin I- (above normal) at least 48 hours before thrombolytic therapy
  • history of CABG during last three months
  • history of previous MI; renal failure (creatinine clearance below 30 mg / dl or creatinine above 1 /4 in women and 1/5 in men)
  • sensitivity to aspirin or clopidogrel and retaplase
  • cardiogenic shock; history of end-stage renal failure or dialysis
  • presence of metformin inhibition

研究者

相似试验